BE 18257B

Known as: BE-18257B 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
PURPOSE Endothelin-1 (ET-1), a peptide produced by the vascular endothelium, causes profound renal vasoconstriction by binding to… (More)
Is this relevant?
1996
1996
Wound contraction is an important event that minimizes the wound defect during the healing process. Involvement of insulin-like… (More)
Is this relevant?
1995
1995
BACKGROUND Prior studies suggest an important role for coronary endothelium in ischemia/reperfusion (I/R) injury. Decreased… (More)
Is this relevant?
Highly Cited
1992
Highly Cited
1992
The novel endothelin (ET) receptor antagonists BE-18257A and BE-18257B were isolated from the fermentation products of… (More)
Is this relevant?
1992
1992
Computer-aided molecular modelling of the endothelin (ET-A) receptor antagonists, BQ-123 and BE-18257B, shows that they have very… (More)
Is this relevant?
1991
1991
Two endothelin (ET)-binding inhibitors, BE-18257A and BE-18257B, which antagonized 125I-ET-1 binding to a porcine aortic smooth… (More)
Is this relevant?
1991
1991
The structures of novel endothelin-binding inhibitors, BE-18257A and BE-18257B, were elucidated by spectral analyses and chemical… (More)
Is this relevant?
1991
1991
A competitive endothelin (ET) antagonist, BE-18257B, was isolated from the fermentation products of Streptomyces misakiensis. It… (More)
Is this relevant?